Molecular analysis uncovers distinct tumor subsets in NIFTP-NS3, suggesting the need for routine diagnostics.
These findings suggest the presence of two distinct tumor subsets within NIFTP-NS3, underscoring the need for routine molecular diagnostics in NIFTP-NS3 to facilitate appropriate clinical management.
No takes yet. Share an insight, caveat, or question.
Sako et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: